TY - JOUR
T1 - Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections
AU - Clements, Abigail
AU - Jenney, Adam W
AU - Farn, Jacinta L
AU - Brown, Lorena Elizabeth
AU - Deliyannis, Georgia
AU - Hartland, Elizabeth Louise
AU - Pearse, Martin J
AU - Maloney, Margaret B
AU - Wesselingh, Steven Lodewyk
AU - Wijburg, Odilia LC
AU - Strugnell, Richard
PY - 2008
Y1 - 2008
N2 - Vaccination strategies against Klebsiella pneumoniae have largely focussed on the polysaccharide capsule. However, the large number and high prevalence of individual capsular serotypes limits the widespread applicability of capsule-based vaccines. This study establishes that immunization with purified LPS can protect mice against lethal challenge with K. pneumoniae, and that subcapsular antibodies directed against purified LPS can be used to treat and/or prevent experimental K. pneumoniae infection in mice. This approach offers potential for prophylaxis and/or therapy against drug-resistant strains of K. pneumoniae.
AB - Vaccination strategies against Klebsiella pneumoniae have largely focussed on the polysaccharide capsule. However, the large number and high prevalence of individual capsular serotypes limits the widespread applicability of capsule-based vaccines. This study establishes that immunization with purified LPS can protect mice against lethal challenge with K. pneumoniae, and that subcapsular antibodies directed against purified LPS can be used to treat and/or prevent experimental K. pneumoniae infection in mice. This approach offers potential for prophylaxis and/or therapy against drug-resistant strains of K. pneumoniae.
UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18725260
M3 - Article
VL - 26
SP - 5649
EP - 5653
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 44
ER -